Effects of Liraglutide on Sudomotor Function in Subjects with Type 2 Diabetes

被引：0
|
作者：
Casellini, Carolina M.
Bailey, Michael D.
Parson, Henri
Siraj, Elias S.
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-420-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
420-P
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Effects of acute exercise on pancreatic endocrine function in subjects with type 2 diabetes
    Knudsen, S. H.
    Karstoft, K.
    Winding, K.
    Holst, J. J.
    Pedersen, B. K.
    Solomon, T. P. J.
    DIABETES OBESITY & METABOLISM, 2015, 17 (02) : 207 - 210
  • [22] Liraglutide in the management of type 2 diabetes
    Wajcberg, Estela
    Amarah, Amatur
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 279 - 290
  • [23] Liraglutide for type 2 diabetes mellitus
    Kela, Ram
    Khunti, Kamlesh
    Davies, Melanie J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (07) : 951 - 959
  • [24] Liraglutide (Victoza) for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1335): : 25 - 27
  • [25] Liraglutide trial in paediatric subjects with type 2 diabetes: safety, tolerability and pharmacokinetics/pharmacodynamics
    Battelino, T.
    Klein, D.
    Chatterjee, D. J.
    Hale, P.
    Chang, C. T.
    Arslanian, S.
    DIABETOLOGIA, 2012, 55 : S7 - S7
  • [26] Sudomotor Dysfunction Is Associated with Decreased Cardiac Diastolic Function in Patients with Type 2 Diabetes
    Chen, Xueyan
    Yang, Xubin
    Xu, Wen
    Deng, Hongrong
    Wu, Jinping
    Yan, Jinhua
    Yao, Bin
    DIABETES, 2021, 70
  • [27] Increased Serum Levels of Uric Acid Are Associated with Sudomotor Dysfunction in Subjects with Type 2 Diabetes Mellitus
    Papanas, N.
    Demetriou, M.
    Katsiki, N.
    Papatheodorou, K.
    Papazoglou, D.
    Gioka, T.
    Kotsiou, S.
    Maltezos, E.
    Mikhailidis, D. P.
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [28] Clinical effects of liraglutide on diabetes control in Japanese type 2 diabetes mellitus patients
    Kawata T.
    Kanamori A.
    Kubota A.
    Maeda H.
    Amamiya H.
    Takai M.
    Kaneshige H.
    Minagawa F.
    Iemitsu K.
    Kaneshiro M.
    Ishikawa M.
    Takeda H.
    Takuma T.
    Mokubo A.
    Machimura H.
    Obana M.
    Miyakawa M.
    Naka Y.
    Terauchi Y.
    Toyoda M.
    Suzuki D.
    Tanaka Y.
    Matsuba I.
    Diabetology International, 2014, 5 (2) : 98 - 104
  • [29] Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes
    Kuriyama, Tsukasa
    Ishibashi, Chisaki
    Kozawa, Junji
    Baden, Megu Y.
    Horii, Tomomi
    Niki, Akiko
    Ozawa, Harutoshi
    Hosokawa, Yoshiya
    Fujita, Yukari
    Sadahiro, Katsuhiko
    Satoh, Tomomi
    Hamaguchi, Tomoya
    Shimomura, Iichiro
    CLINICAL NUTRITION ESPEN, 2024, 59 : 208 - 213
  • [30] Early Liraglutide Treatment Improves β-Cell Function in Patients With Type 2 Diabetes
    Kondo, Yoshinobu
    Satoh, Shinobu
    Inoue, Yuichiro
    Kimura, Masayo
    Hirama, Masayuki
    Nezu, Uru
    Terauchi, Yasuo
    DIABETES, 2013, 62 : A264 - A264
12345